Background/Aims: Non-steroidal anti-inflammatory drugs cause enterocyte damage inducing an increase of intestinal permeability. Tight junctions are the key structures in the permeability of the intestinal mucosa. ZO-1 is a tight junction associated protein considered a good marker of their integrity. It has been suggested that probiotics could play a protective role in the intestinal barrier function. We determined, in vitro, whether the heat-killed Lactobacillus acidophilus strain LB (LaLB) with its spent culture supernatant protects tight junctions of HT-29 cells from aspirin (ASA) damage. Methods: HT-29 cells were treated with ASA alone or ASA and LaLB with its spent culture supernatant together. Morphological alterations of tight junctions were evaluated by immunofluorescence using an anti-ZO-1 antibody. Moreover, a semiquantitative assay for ZO-1 was performed by Western blot. Results: Immunofluorescence analysis showed a fragmented and granulous ZO-1 staining, after ASA treatment. Using both ASA and LaLB with its spent culture supernatant together, we found a fine continuous linear web at cell-cell contacts similarly to control. Western blot revealed that ASA inhibited ZO-1 expression and LaLB with its spent culture supernatant counteracted this effect. Conclusions: This pilot study shows, for the first time, the protective effect of LaLB with its spent culture supernatant on tight junctions from ASA damage. These results suggest that probiotics could play a role in the prevention of ASA-induced alterations of intestinal permeability.

Journal Section:
Original Paper
Keywords:
Lactobacillus, Tight junctions, ZO-1, Aspirin
1.
Bjarnason I, Peters TJ, Levi AJ: Intestinal permeability: Clinical correlates. Dig Dis 1986;4:83–92.
2.
Bjarnason I, Hayllar J, MacPherson AJ, Russell AS: Side effects of non-steroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 1993;104:1832–1847.
3.
Bjarnason I: Intestinal permeability. Gut 1994;35:S18–S22.
4.
Gumbiner B: Breaking through the tight junction barrier. J Cell Biol 1993;123:1631–1633.
5.
Madara JL: Regulation of the movement of solutes across tight junctions. Annu Rev Physiol 1998;60:143–159.
6.
Anderson JM, Van Itallie CM: Tight junctions and the molecular basis for regulation of paracellular permeability. Am J Physiol 1995;269:G467–G475.
7.
Gasbarrini G, Montalto M: Structure and function of tight junctions. Role in intestinal barrier. Ital J Gastrenterol Hepatol 1999;31:481–488.
8.
Jensen-Jarolim E, Gajdzik L, Haberl I, Graf J: Hot spice influence permeability of human intestinal epithelial monolayers. J Nutr 1998;128:577–581.
9.
Montalto M, Cuoco L, Ricci R, Maggiano M, Vecchio FB, Gasbarrini G: Immunohistochemical analysis of ZO-1 in the duodenal mucosa of patients with untreated celiac disease. Digestion 2002;65:227–233.
10.
Montalto M, Arancio F, Izzi D, Cuoco L, Curigliano V, Manna R, Gasbarrini G: I probiotici: storia, definizione, requisiti e possibili applicazioni terapeutiche. Ann Ital Med Int 2002;17:157–165.
11.
Saxelin M, Pessi T, Salminem S: Fecal recovery following oral administration of Lactobacillus strain GG (ATCC 53103) in gelatine capsules to healthy volunteers. Int J Food Microbiol 1995;25:199–203.
12.
Silva M, Jacobus NV, Deneke C, Gorbach SL: Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother 1987;31:1231–1233.
13.
Athir A, Rekhif N, Michel M, Lefebvre G: Detection of bacteriocins produced by Lactobacillus plantarum strains isolated from different foods. Microbios 1993;75:117–123.
14.
Isolauri E, Sütas Y, Kankaanpää P, Arvilommi H, Salminen S: Probiotics: Effects on immunity. Am J Clin Nutr 2001;73:444S–450S.
15.
Simakachorn N, Pichaipat V, Rithipornpaisarn P, Kongkaew C, Tongpradit P, Varavithya W: Clinical evaluation of the addition of lyophilized, heat-killed Lactobacillus acidophilus LB to oral rehydration therapy in the treatment of acute diarrhea in children. J Pediatr Gastroenterol Nutr 2000;30:68–72.
16.
Lichtenberger LM, Wang ZM, Romero JJ, Ulloa C, Perex JC, Giraud MN: NSAIDs associate with zwitterionic phospholipids: Insight into the mechanism and reversal gastrointestinal injury. Nat Med 1995;1:154–158.
[PubMed]
https://doi.org/10.1038/nm0295-154
17.
Qiao L, Hanif R, Sphicas E: Effect of aspirin on induction of apoptosis in HT-29. Biochem Pharmacol 1998;55:53–64.
18.
Hilgendorf C, Spahn-Langguth H, Regardh CG, Lipka E, Amidon GL, Langguth P: CaCO2 versus CaCO2/HT29-MTX co-cultured cell lines: Permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. J Pharm Sci 2000;89:63–75.
19.
Uejima M, Kinouchi T, Kataoka K, Hiraoka I, Ohnishi Y: Role of intestinal bacteria in ileal ulcer formation in rats treated with a non-steroidal anti-inflammatory drug. Microbiol Immunol 1996;40:553–560.
20.
Gotteland M, Cruchet S, Verbeke S: Effect of Lactobacillus ingestion on the gastrointestinal mucosal barrier alterations induced by indomethacin in humans. Aliment Pharmacol Ther 2001;15:11–17.
© 2004 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2004
You do not currently have access to this content.